Home (page 2)

Tag Archives: multidistrict litigation

Yaz plaintiff loses bid to unseal documents for FDA

The Food and Drug Administration will not be given access to documents relating to the safety of drospirenone-containing oral contraceptives that pharmaceutical company Bayer has kept confidential in the Yaz and Yasmin multidistrict product liability litigation.

Read More »

Panel weighs consolidation of Darvon/Darvocet litigation

SAN FRANCISCO – In oral arguments before the multidistrict litigation panel on Thursday in San Francisco, lawyers sparred over whether litigation involving the popular pain medications Darvon and Darvocet should be consolidated and if so, where they should be centralized.

Read More »